Effectiveness of Mobile-health Self Management on Quality of Life of Patients Undergoing Chemotherapy
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cancer
- Sponsor
- Universitas Muhammadiyah Yogyakarta
- Enrollment
- 50
- Primary Endpoint
- Patient's Self-efficacy
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
The study will design and evaluate the use of mobile-health based self-management on self-efficacy and quality of life of patients undergoing chemotherapy.
Detailed Description
The study will design and evaluate the use of mobile-health based self-management on self-efficacy and quality of life of patients undergoing chemotherapy.
Investigators
Erna Rochmawati
Associate Professor
Universitas Muhammadiyah Yogyakarta
Eligibility Criteria
Inclusion Criteria
- •adult patients diagnosed with cancer
- •patients who use smart phone
Exclusion Criteria
- •patients with cancer with comorbidity
Outcomes
Primary Outcomes
Patient's Self-efficacy
Time Frame: four weeks
The patients self-efficacy will be measured pre and post intervention. The measurement will use the Self-Efficacy for Managing Chronic Disease Scale. The scale has been widely used in cancer setting. Respondents will rate their confidence to perform six self-management behaviours (1 = 'not at all confident' to 10 = 'totally confident'). A mean score is calculated (range 1 to 10). A high score indicates high self-efficacy.
Patient's Quality of life
Time Frame: Four weeks
The patient's quality of life will be assessed before (T0) and after intervention (T1). The measurement will use EORTC. The score will range from 0-100, where higher score reflects a better quality of life.